Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of paricalcitol injection.
Subjects will administer clinical supplies 3 times a week, 40 weeks at dialysis session in
dose-titration manner, following 12 weeks of treatment in the dose-response study, M10-309
(NCT00667576).